Steroids or immunoglobulins for severe sudden heart inflammation
Part of Heart & circulation clinical trials.
This trial tests whether giving steroids, immunoglobulins, or both can help people with a sudden, severe heart muscle inflammation (myocarditis) that causes shock or dangerous heart rhythms. The goal is to see if these treatments improve recovery compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sudden heart muscle inflammation (myocarditis) within the last month.
- Your heart is struggling to pump blood (cardiogenic shock) or you have dangerous heart rhythm problems (electrical storm).
- You need medications or a device to support your blood pressure or heart function, and this support started less than 72 hours ago.
- You are 15 years old or older.
- You are not pregnant, breastfeeding, or within 6 months after giving birth.
- You do not have other heart conditions like prior heart failure, blocked arteries causing this episode, or stress-induced heart weakness (Tako-Tsubo).
- You do not have an autoimmune disease that already requires immune-suppressing treatment.
- You are not currently taking steroids or receiving immunoglobulin therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether steroid medicine helps people hospitalized with suspected acute myocarditis (inflammation of the heart). Participants are randomly assigned to receive steroids or a placebo, and the trial looks at outcomes after the acute episode starts.
This trial tests if non-steroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, help people with acute myocarditis (inflammation of the heart muscle) who are hospitalized but have normal heart function. It aims to see if these drugs can reduce inflammation and improve recovery.
This study follows people who have been hospitalized for a sudden inflammation of the heart muscle (myocarditis) to understand their risk of developing irregular heartbeats (arrhythmias). It aims to identify who might need closer monitoring or extra treatment to prevent complications.
This study is creating a national registry to learn more about inflammatory myocardial disease (inflammation of the heart muscle). If you have symptoms like chest pain, shortness of breath, palpitations, or certain test results, you may be eligible to join and help advance research.
This study tests a new imaging technique that might better detect heart muscle inflammation (myocarditis). It uses a special contrast agent and ultrasound to see inflammation more clearly, which could help guide treatment.
This Phase 3 trial tests abatacept to treat myocarditis (inflammation of the heart muscle) caused by immune checkpoint cancer medicines. It may help patients recover faster and safely manage this serious side effect while they are in the hospital.
Hear when a new Myocarditis Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.